Development of New Prenatal Diagnostic Tests From Maternal Blood

University Hospital, Strasbourg, France

Status: Terminated

Conditions: Hereditary Diseases

Treatments: Genetic: Blood samples

Study type: Interventional

Funder types: Other

Identifiers

NCT00314691

3612

Details and patient eligibility

About

After extraction of the cell-free DNA circulating in maternal plasma, we aim at developing new techniques for fetal DNA enrichment to perform fetal gender determination, and indirect diagnosis of inherited diseases like Cystic Fibrosis, Huntington Disease, Myotonic Dystrophy, B-Thalassaemia...

Enrollment: 10 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Mother and father-to-be both older than 18 years old
• Mother and father-to-be affiliated to social security
• Mother and father-to-be have good understanding of the protocol
• Pregnancy of the mother-to-be attested

Exclusion criteria

• Mother and father-to-be are younger than 18 years old
• Mother and/or father-to be refusing to participate

Trial design

Primary purpose: Diagnostic

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)